Riskpilot← Back to searchSign inGet full accessP.LAB AB
ABActiveOrg 5590006580Brantingsgatan 24Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20150 employees
Revenue 2024
SEK 2,4M
+12% vs 2023
EBITDA margin
10.2%
+1945% vs 2023
Equity ratio
24.6%
Financial strength
Net profit 2024
SEK 41K
+40% vs 2023
| Revenue | SEK 2,4M | +12% |
| EBITDA | SEK 245K | +1945% |
| Net profit | SEK 41K | +40% |
| Total assets | SEK 1,3M | +50% |
| Equity | SEK 310K | +15% |
| Employees | 0 | — |
Legal name
P.LAB AB
Org number
5590006580
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
16 januari 2015
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva tandteknisk verksamhet och tandvård samt annan därmed förenlig verksamhet.
Address
Brantingsgatan 24
Email
pe@plabdental.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 849 | 2 391 | 2 253 | 2 147 | 2 404 |
| Staff expenses | — | — | −917 | −706 | −516 |
| EBITDA | 267 | 271 | −36 | −13 | 245 |
| Depreciation & amort. | −180 | −0 | −32 | −143 | −124 |
| EBIT | 87 | 271 | −68 | −157 | 122 |
| Net financials | −88 | −70 | −1 | −3 | −40 |
| Profit before tax | 0 | 12 | −17 | 40 | 82 |
| Tax | −0 | −11 | 16 | −11 | −41 |
| Net profit | 0 | 1 | −2 | 30 | 41 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 336 | 953 | 1 070 | 839 | 1 263 |
| Equity | 217 | 218 | 216 | 269 | 310 |
| Long-term debt | 581 | 39 | 96 | 155 | 560 |
| Short-term debt | 185 | 230 | 266 | 124 | 101 |
| Total debt | 766 | 269 | 362 | 279 | 661 |
EBITDA margin
10.2%
This company
15.8%
Market median
-35% vs market
20202024
Equity ratio
24.6%
This company
38.2%
Market median
-36% vs market
20202024
Return on equity
13.3%
This company
18.4%
Market median
+28% vs market
20202024
Net profit margin
1.7%
This company
8.1%
Market median
-79% vs market
20202024
Asset turnover
1.90×
This company
1.12×
Market median
+70% vs market
20202024
Debt / equity
3.07×
This company
0.62×
Market median
-395% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PE Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
| Former (2) | ||
| Chairman | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of P.LAB AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Eric Ekblom | Chief Executive Officer | 0 companies |
| Greta Sofie Viktoria Ekblom | Chairman | 0 companies |
| Ida Filippa Kristin Ekblom | Deputy Board Member | 0 companies |
| Per Albin Love Ekblom | Deputy Board Member | 0 companies |